Key Points
- Phyllis Gotlib sold 3,707 shares of American Well on Jan. 2 at an average price of $4.85 for about $17,979, trimming her stake by 3% to 119,870 shares (≈$581,370).
- Shares jumped on the day, opening at $5.21 (up ~7.5%); the stock trades between a 50-day SMA of $4.42 and 200-day SMA of $6.14, with a 12-month range of $3.71–$12.95 and a market cap around $85.4 million.
- Fundamentals and sentiment remain challenged: Amwell reported a loss per share of $1.74 (beating estimates) and revenue of $56.3M, but has negative ROE/net margins; analysts’ consensus is "Hold" with an average target of $7.58.
American Well Corporation (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 3,707 shares of the business's stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $4.85, for a total transaction of $17,978.95. Following the completion of the sale, the insider owned 119,870 shares of the company's stock, valued at approximately $581,369.50. The trade was a 3.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Phyllis Gotlib also recently made the following trade(s):
- On Monday, December 1st, Phyllis Gotlib sold 3,574 shares of American Well stock. The shares were sold at an average price of $4.06, for a total transaction of $14,510.44.
American Well Stock Up 7.5%
American Well stock opened at $5.21 on Tuesday. The firm has a fifty day simple moving average of $4.42 and a two-hundred day simple moving average of $6.14. American Well Corporation has a twelve month low of $3.71 and a twelve month high of $12.95. The company has a market capitalization of $85.35 million, a PE ratio of -0.72 and a beta of 1.26.
American Well (NYSE:AMWL - Get Free Report) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($1.74) EPS for the quarter, topping the consensus estimate of ($1.83) by $0.09. American Well had a negative return on equity of 39.80% and a negative net margin of 42.80%.The firm had revenue of $56.29 million for the quarter, compared to the consensus estimate of $54.56 million. As a group, equities analysts expect that American Well Corporation will post -9.34 earnings per share for the current fiscal year.
Institutional Investors Weigh In On American Well
Institutional investors and hedge funds have recently modified their holdings of the stock. Goldman Sachs Group Inc. boosted its stake in shares of American Well by 280.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company's stock valued at $510,000 after purchasing an additional 47,745 shares in the last quarter. Jane Street Group LLC lifted its holdings in American Well by 232.9% in the first quarter. Jane Street Group LLC now owns 64,112 shares of the company's stock worth $505,000 after buying an additional 44,852 shares during the period. Acadian Asset Management LLC lifted its holdings in American Well by 19.5% in the first quarter. Acadian Asset Management LLC now owns 188,217 shares of the company's stock worth $1,481,000 after buying an additional 30,669 shares during the period. Corton Capital Inc. boosted its position in American Well by 71.7% during the 2nd quarter. Corton Capital Inc. now owns 27,402 shares of the company's stock valued at $244,000 after acquiring an additional 11,445 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of American Well during the 2nd quarter worth approximately $89,000. 56.05% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the company. Weiss Ratings reissued a "sell (e+)" rating on shares of American Well in a research note on Wednesday, October 8th. Wall Street Zen cut shares of American Well from a "hold" rating to a "sell" rating in a research report on Saturday, November 8th. Stifel Nicolaus cut their price target on shares of American Well from $8.00 to $6.00 and set a "hold" rating on the stock in a report on Wednesday, November 5th. Wells Fargo & Company lowered their price objective on shares of American Well from $12.00 to $9.00 and set an "overweight" rating for the company in a research note on Wednesday, November 5th. Finally, Morgan Stanley cut their target price on American Well from $10.50 to $6.00 and set an "equal weight" rating on the stock in a research note on Thursday, December 18th. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $7.58.
Get Our Latest Stock Report on American Well
American Well Company Profile
(
Get Free Report)
American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.
The company's core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
